what companies make glp 1 drugs GLP-1 Market Trends and Global Forecasts Report 2025: A $157.5 Bn Market by 2035 Supplement brands' role could change
Description
One study from February 2025, for instance, suggests that people who take glucagon-like peptide-1 receptor agonist medication like Ozempic to treat diabetes have a lower depression risk than peers taking other types of drugs for this metabolic condition
Ochner CN, Gibson C, Shanik M, Goel V, Geliebter A
Nausea, vomiting, stomach cramps, bloating, constipation, and diarrhea are the most common, along with fatigue, headaches, and dizziness
Mitochondrial dysfunction has negative effects on the body and is believed to be an important factor in aging and disease
Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity
Pharmacists are a staple in the community
